Skip to content
Live funding
Sesame Summit 2027
Sesamers
M

Mission BioCapital

● Actively deploying Cambridge, MA and San Francisco, US · Founded 2009

Investment thesis

Venture capital backing and incubating early-stage biotech companies.

Sesamers tracks 2 portfolio companies across 2 rounds, 1 of them as lead investor. Its most recent tracked deal: Oyster Therapeutics, Nov 2026.

Portfolio

Past investments

Company Round Role Date Round size
Oyster Therapeutics London, United Kingdom Read the announcement → Series A Participant Nov 2026 €54.1M
Breye Therapeutics Hørsholm, Denmark Read the announcement → Series A Lead Sep 2026 €67.5M

Sesamers coverage

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.